What? Now a Respiratory Syncytial Virus Epidemic

Just when we were celebrating some attenuation of COVID-19 contagion, there are resurgent, new outbreaks of respiratory syncytial virus (RSV) and influenza infections.Our previous coronavirus precautions might have predisposed our population to a higher incidence of illness now.These three respiratory ailments initially present in a similar fashion, and each of them might, via lowered immunity, augment the chances of contracting the other infections.RSV is a single-stranded RNA virus belonging to the Paramyxoviridae family.It was discovered in chimpanzees in 1955 and was later confirmed to be a human pathogen.The RSV structure is that of a bilipid layer envelope surrounding a ribonucleoprotein core, with several membrane proteins that aid attachment and fusion to host cells.[1] Serious illness associated with RSV infection occurs mainly in young children.Symptoms of infection most commonly appear around four to six days after exposure to the virus and may include dry cough, congested runny nose, sneezing, sore throat, headache, and fever.[2]